Related Experiment Video
Updated: Sep 9, 2025

06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
38.3K
EcoHIV Infection Promotes Atherosclerosis Progression in LDLR-Deficient Mice.
Ivan Pinos1, Amparo Blanco1, Jennifer Kelschenbach2
1Division of Nutritional Sciences (I.P., A.B., J.A.), University of Illinois Urbana-Champaign.
Arteriosclerosis, Thrombosis, and Vascular Biology
|September 4, 2025
Summary
This study reveals how HIV infection impacts cardiovascular disease using a mouse model. EcoHIV infection in mice mimics human immunodeficiency virus-associated atherosclerosis, offering insights for new treatments.
Area of Science:
- Cardiovascular Science
- Virology
- Immunology
Background:
- People with HIV face increased risk of atherosclerotic cardiovascular disease (ASCVD).
- Molecular mechanisms linking HIV and ASCVD are poorly understood.
- Lack of suitable animal models hinders research.
Purpose of the Study:
- To investigate the impact of HIV on ASCVD pathogenesis.
- To establish a relevant animal model for HIV-associated cardiovascular disease.
- To explore molecular changes in atherosclerosis due to HIV infection.
Main Methods:
- Infection of atheroprone low-density lipoprotein receptor-deficient (Ldlr-/-) mice with chimeric HIV (EcoHIV).
- Analysis of inflammatory monocyte markers, recruitment, and lesion composition.
- Assessment of lesion vulnerability, necrotic core size, and collagen content.
Main Results:
- EcoHIV infection increased inflammatory monocytes and their recruitment to lesions.
- Lesions showed increased vulnerability, larger necrotic cores, and reduced collagen.
- Active EcoHIV replication was observed within atherosclerotic lesions.
- These changes occurred independently of plasma lipid profiles or lesion size.
Conclusions:
- EcoHIV infection in Ldlr-/- mice effectively models HIV-associated ASCVD.
- Findings highlight potential therapeutic targets for cardiovascular complications in people with HIV.
- This model provides a platform for developing interventions for HIV-infected individuals at high cardiovascular risk.
Related Concept Videos
Atherosclerosis I: Introduction
74
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
74
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Inflammation
55.0K
Overview
55.0K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
37
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
37
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33

